-
1
-
-
0037514257
-
Decreased β-amyloidl-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
-
Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, et al Decreased β-amyloidl-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003; 289: 2094-2103
-
(2003)
JAMA
, vol.289
, pp. 2094-2103
-
-
Sunderland, T.1
Linker, G.2
Mirza, N.3
Putnam, K.T.4
Friedman, D.L.5
Kimmel, L.H.6
-
2
-
-
1542782550
-
Novel cadherinrelated membrane proteins, Alcadeins, enhance the Xll-like protein-mediated stabilization of amyloid β-protein precursor metabolism
-
Araki Y, Tomita S, Yamaguchi H, Miyagi N, Sumioka A, Kirino Y, et aL Novel cadherinrelated membrane proteins, Alcadeins, enhance the Xll-like protein-mediated stabilization of amyloid β-protein precursor metabolism. J Biol Chem 2003; 278: 49448-49458.
-
(2003)
J Biol Chem
, vol.278
, pp. 49448-49458
-
-
Araki, Y.1
Tomita, S.2
Yamaguchi, H.3
Miyagi, N.4
Sumioka, A.5
Kirino, Y.6
-
3
-
-
2642566848
-
Coordinated metabolism of Alcadein and amyloid β-protein precursor regulates FE65- dependent gene transactivation
-
Araki Y. Miyagi N, Kato N, Yoshida T, Wada S. Nishimura M, et al Coordinated metabolism of Alcadein and amyloid β-protein precursor regulates FE65- dependent gene transactivation. J Biol Chem 2004; 279: 24343-24354.
-
(2004)
J Biol Chem
, vol.279
, pp. 24343-24354
-
-
Araki, Y.1
Miyagi, N.2
Kato, N.3
Yoshida, T.4
Wada, S.5
Nishimura, M.6
-
4
-
-
33947607769
-
The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport
-
Araki Y, Kawano T, Taru H, Saito Y, Wada S, Miyamoto K, et aL The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport EMBO J 2007; 26: 1475-1486.
-
(2007)
EMBO J
, vol.26
, pp. 1475-1486
-
-
Araki, Y.1
Kawano, T.2
Taru, H.3
Saito, Y.4
Wada, S.5
Miyamoto, K.6
-
5
-
-
33645280382
-
γ-secretase as a therapeutic for treatment of Alzheimer's disease
-
Tomita T, Iwatsubo T: γ-secretase as a therapeutic for treatment of Alzheimer's disease. Curr Pharm Des 2006; 12: 661-670.
-
(2006)
Curr Pharm des
, vol.12
, pp. 661-670
-
-
Tomita, T.1
Iwatsubo, T.2
-
6
-
-
70350311593
-
-
Submitted
-
Hata S, Fujishige S, Araki Y, Kato N, Araseki M, et aL Covariant processing of APP and Alcadein by γ- secretase dysfunction and its relation to the sporadic Alzheimer's disease. 2009 Submitted.
-
(2009)
Covariant Processing of APP and Alcadein by γ- Secretase Dysfunction and Its Relation to the Sporadic Alzheimer's Disease
-
-
Hata, S.1
Fujishige, S.2
Araki, Y.3
Kato, N.4
Araseki, M.5
-
7
-
-
70350263188
-
-
Submitted
-
Hata S, Fujishige S, Araki Y, Taniguchi M, Urakami K, et al Alcadein metabolite analysis and evidence for mis- processing of multiple γ secretase substrates in Alzheimer's disease. 2009 Submitted.
-
(2009)
Alcadein Metabolite Analysis and Evidence for Mis- Processing of Multiple γ Secretase Substrates in Alzheimer's Disease
-
-
Hata, S.1
Fujishige, S.2
Araki, Y.3
Taniguchi, M.4
Urakami, K.5
|